A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Fecal Microbiota Composition Differs Between Children With beta-Cell Autoimmunity and Those Without




Tekijätde Goffau MC, Luopajarvi K, Knip M, Ilonen J, Ruohtula T, Harkonen T, Orivuori L, Hakala S, Welling GW, Harmsen HJ, Vaarala O

Julkaisuvuosi2013

JournalDiabetes

Tietokannassa oleva lehden nimiDiabetes

Lehden akronyymiDiabetes

Numero sarjassa4

Vuosikerta62

Numero4

Aloitussivu1238

Lopetussivu1244

Sivujen määrä7

ISSN0012-1797

DOIhttps://doi.org/10.2337/db12-0526


Tiivistelmä
The role of the intestinal microbiota as a regulator of autoimmune diabetes in animal models is well-established, but data on human type 1 diabetes are tentative and based on studies including only a few study subjects. To exclude secondary effects of diabetes and HLA risk genotype on gut microbiota, we compared the intestinal microbiota composition in children with at least two diabetes-associated autoantibodies (n = 18) with autoantibody-negative children matched for age, sex, early feeding history, and HLA risk genotype using pyrosequencing. Principal component analysis indicated that a low abundance of lactate-producing and butyrate-producing species was associated with β-cell autoimmunity. In addition, a dearth of the two most dominant Bifidobacterium species, Bifidobacterium adolescentis and Bifidobacterium pseudocatenulatum, and an increased abundance of the Bacteroides genus were observed in the children with β-cell autoimmunity. We did not find increased fecal calprotectin or IgA as marker of inflammation in children with β-cell autoimmunity. Functional studies related to the observed alterations in the gut microbiome are warranted because the low abundance of bifidobacteria and butyrate-producing species could adversely affect the intestinal epithelial barrier function and inflammation, whereas the apparent importance of the Bacteroides genus in development of type 1 diabetes is insufficiently understood.



Last updated on 2024-26-11 at 21:42